XML 88 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1

COMMITMENTS AND CONTINGENCIES (Details 2) - USD ($) $ in Millions	Mar. 21, 2007	Dec. 31, 2017
SkyePharma Holding, Inc.
Commitments
Total milestone payments paid		$ 36.0
SkyePharma Holding, Inc. | Maximum
Commitments
Milestone payments for EXPAREL agreed in connection with acquisition		$ 62.0
PPI-California
Commitments
Initial purchase price for acquisition	$ 19.6

X

- Definition

Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.

+ References

No definition available.

+ Details

Name:	pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition
Namespace Prefix:	pcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Total Milestone Payments Yet to be Paid for Sale of Product in Connection with Acquisition

+ References

No definition available.

+ Details

Name:	pcrx_TotalMilestonePaymentsYettobePaidforSaleofProductinConnectionwithAcquisition
Namespace Prefix:	pcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionContingentConsiderationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_CounterpartyNameAxis=pcrx_SkyePharmaHoldingIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=pcrx_CaliforniaOperatingSubsidiaryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: